Breast Cancer Clinical Trials in Shijiazhuang, Hebei
7 recruitingShijiazhuang, Hebei, China
Showing 1–7 of 7 trials
Recruiting
Not Applicable
Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases
Breast CancerRadiotherapy
Fudan University1,608 enrolled15 locationsNCT07469267
Recruiting
Phase 2
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
Breast Cancer
Hebei Medical University Fourth Hospital144 enrolled1 locationNCT06107673
Recruiting
Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Breast Cancer
Laekna Limited256 enrolled55 locationsNCT04851613
Recruiting
Phase 2
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Breast Cancer
Hebei Medical University Fourth Hospital520 enrolled1 locationNCT04138719
Recruiting
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Breast Cancer
Hebei Medical University Fourth Hospital420 enrolled1 locationNCT05578053
Recruiting
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
Breast CancerHER2-negative Breast Cancer
Hebei Medical University Fourth Hospital620 enrolled1 locationNCT06375798
Recruiting
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Breast CancerLung Cancer
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123